The role of mTOR in lipid homeostasis and diabetes progression

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 5, 2015, Pages 340-346

  Chakrabarti, Partha ^a   Kandror, Konstantin V ^b  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adipose triglyceride lipase; Egr1; lipid partitioning; mTOR; sterol regulatory element binding protein

Indexed keywords

ACYLGLYCEROL LIPASE; EARLY GROWTH RESPONSE FACTOR 1; FAT DROPLET; FATTY ACID; INITIATION FACTOR 4A; INITIATION FACTOR 4E; INITIATION FACTOR 4F; INITIATION FACTOR 4G; INSULIN; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MESSENGER RNA; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCOUPLING PROTEIN 1; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ADIPOGENESIS; CELL DIFFERENTIATION; DIABETES MELLITUS; HEALTH CARE COST; INSULIN RESISTANCE; LIFE EXPECTANCY; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIPOTOXICITY; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; OVERNUTRITION; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; STARVATION; TRANSCRIPTION INITIATION; DISEASE COURSE; GENETICS; HOMEOSTASIS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY;

DIABETES MELLITUS; DISEASE PROGRESSION; HOMEOSTASIS; HUMANS; LIPID METABOLISM; OBESITY; TOR SERINE-THREONINE KINASES;

EID: 84960412904     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000187     Document Type: Review

References (96)

1. Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 2011; 22:94-102.
2. Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013; 126:1713-1719.
3. Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 2014; 15:155-162.
4. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335:1638-1643.
5. Zheng X, Liang Y, He Q, et al. Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids. Intl J Mol Sci 2014; 15:20753-20769.
6. Oshiro N, Rapley J, Avruch J. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging. J Biol Chem 2014; 289:2658-2674.
7. Sancak Y, Peterson TR, Shaul YD, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320:1496-1501.
8. Groenewoud MJ, Zwartkruis FJ. Rheb and Rags come together at the lysosome to activate mTORC1. Biochem Soc Trans 2013; 41:951-955.
9. Lamming DW, Sabatini DM. A central role for mTOR in lipid homeostasis. Cell Metab 2013; 18:465-469.
10. Pajvani UB, Qiang L, Kangsamaksin T, et al. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTORC1 stability. Nat Med 2013; 19:1054-1060.
11. Chakrabarti P, English T, Shi J, et al. The mTOR complex 1 suppresses lipolysis, stimulates lipogenesis and promotes fat storage. Diabetes 2010; 59:775-781.
12. Duvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010; 39:171-183.
13. Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A 2010; 107:3441-3446.
14. Porstmann T, Santos CR, Griffiths B, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-Dependent cell growth. Cell Metab 2008; 8:224-236.
15. Yecies JL, Zhang HH, Menon S, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-Dependent and independent pathways. Cell Metab 2011; 14:21-32.
16. Peterson TR, Sengupta SS, Harris TE, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011; 146:408-420.
17. Kenerson HL, Yeh MM, Yeung RS. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS One 2011; 6:e18075.
18. Yecies JL, Manning BD. mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl) 2011; 89:221-228.
19. Kenerson HL, Subramanian S, McIntyre R, et al. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. PLoS One 2015; 10:e0117000.
20. Hagiwara A, Cornu M, Cybulski N, et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 2012; 15:725-738.
21. Yuan M, Pino E, Wu L, et al Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
22. Jenkins CM, Mancuso DJ, Yan W, et al. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004; 279:48968-48975.
23. Villena JA, Roy S, Sarkadi-Nagy E, et al. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem 2004; 279:47066-47075.
24. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004; 306:1383-1386.
25. Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012; 15:279-291.
26. Smirnova E, Goldberg EB, Makarova KS, et al. ATGL has a key role in lipid droplet/adiposome degradation in mammalian cells. EMBO Rep 2006; 7:106-113.
27. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312:734-737.
28. Bezaire V, Mairal A, Ribet C, et al. Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem 2009; 284:18282-18291.
29. Miyoshi H, Perfield JW 2nd, Obin MS, et al. Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 2008; 105:1430-1436.
30. Kershaw EE, Hamm JK, Verhagen LA, et al. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006; 55:148-157.
31. Gronke S, Mildner A, Fellert S, et al. Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab 2005; 1:323-330.
32. Kurat CF, Natter K, Petschnigg J, et al. Obese yeast: triglyceride lipolysis is functionally conserved from mammals to yeast. J Biol Chem 2006; 281:491-500.
33. Chakrabarti P, Kim JY, Singh M, et al. Insulin inhibits lipolysis in adipocytes via the evolutionary conserved mTORC1-Egr1-ATGL-mediated pathway. Mol Cell Biol 2013; 33:3659-3666.
34. Singh M, Shin YK, Yang X, et al. 4E-BPs control fat storage by regulating the expression of Egr1 and ATGL. J Biol Chem 2015; 290:17331-17338.
35. Fowler T, Sen R, Roy AL. Regulation of primary response genes. Mol Cell 2011; 44:348-360.
36. Pagel JI, Deindl E. Early growth response 1-A transcription factor in the crossfire of signal transduction cascades. Indian J Biochem Biophys 2011; 48:226-235.
37. Thiel G, Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002; 193:287-292.
38. Thiel G, Mayer SI, Muller I, et al. Egr-1-A Ca(2+)-regulated transcription factor. Cell Calcium 2010; 47:397-403.
39. Brand E, Herrmann SM, Nicaud V, et al. Identification of two polymorphisms in the early growth response protein-1 gene: possible association with lipid variables. J Mol Med (Berl) 2000; 78:81-86.
40. Boyle KB, Hadaschik D, Virtue S, et al. The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation. Cell Death Differ 2009; 16:782-789.
41. Muller I, Rossler OG, Wittig C, et al. Critical role of Egr transcription factors in regulating insulin biosynthesis, blood glucose homeostasis, and islet size. Endocrinology 2012; 153:3040-3053.
42. Shen N, Yu X, Pan FY, et al. An early response transcription factor, egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. J Biol Chem 2011; 286:14508-14515.
43. Gokey NG, Lopez-Anido C, Gillian-Daniel AL, et al. Early growth response 1 (egr1) regulates cholesterol biosynthetic gene expression. J Biol Chem 2011; 286:29501-29510.
44. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15:807-826.
45. Singh M, Kaur R, Lee MJ, et al. Fat specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of Egr1 on transcription of adipose triglyceride lipase. J Biol Chem 2014; 289:14481-14487.
46. Luong N, Davies CR, Wessells RJ, et al. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab 2006; 4:133-142.
47. Birse RT, Choi J, Reardon K, et al. High-fat-Diet-induced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. Cell Metab 2010; 12:533-544.
48. Hsu PP, Kang SA, Rameseder J, et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011; 332:1317-1322.
49. Yu Y, Yoon SO, Poulogiannis G, et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011; 332:1322-1326.
50. Deng Y, Bhattacharya S, Swamy OR, et al. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action. J Biol Chem 2003; 278:39311-39322.
51. Liu M, Bai J, He S, et al. Grb10 promotes lipolysis and thermogenesis by phosphorylation-Dependent feedback inhibition of mTORC1. Cell Metab 2014; 19:967-980.
52. Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature 2009; 458:1131-1135.
53. Rambold AS, Cohen S, Lippincott-Schwartz J. Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics. Dev Cell 2015; 32:678-692.
54. Goorden SM, Hoogeveen-Westerveld M, Cheng C, et al. Rheb is essential for murine development. Mol Cell Biol 2011; 31:1672-1678.
55. Carnevalli LS, Masuda K, Frigerio F, et al. S6K1 plays a critical role in early adipocyte differentiation. Dev Cell 2010; 18:763-774.
56. Polak P, Cybulski N, Feige JN, et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399-410.
57. Zhang HH, Huang J, Duvel K, et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 2009; 4:e6189.
58. Yeh WC, Bierer BE, McKnight SL. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A 1995; 92:11086-11090.
59. Kim JE, Chen J. Regulation of peroxisome proliferator-Activated receptorgamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004; 53:2748-2756.
60. Yoon MS, Zhang C, Sun Y, et al. Mechanistic target of rapamycin controls homeostasis of adipogenesis. J Lipid Res 2013; 54:2166-2173.
61. Cho HJ, Park J, Lee HW, et al. Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 2004; 321:942-948.
62. El-Chaar D, Gagnon A, Sorisky A Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
63. Um SH, Frigerio F, Watanabe M, et al. Absence of S6K1 protects against ageand diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431:200-205.
64. Le Bacquer O, Petroulakis E, Paglialunga S, et al Elevated sensitivity to dietinduced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.
65. Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9:367-377.
66. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007; 87:507-520.
67. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46:3-10.
68. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: pathogenesis and treatment. Lancet 2008; 371:2153-2156.
69. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008; 9:162-176.
70. Qatanani M, Lazar MA. Mechanisms of obesity-Associated insulin resistance: many choices on the menu. Genes Dev 2007; 21:1443-1455.
71. Fraze E, Donner CC, Swislocki AL, et al. Ambient plasma free fatty acid concentrations in noninsulin-Dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61:807-811.
72. Abbasi F, McLaughlin T, Lamendola C, et al. Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 2000; 49:151-154.
73. Reaven GM, Chang H, Hoffman BB. Impaired insulin-mediated inhibition of lipolysis and glucose transport with aging. Horm Metab Res 1989; 21:168-171.
74. Coen PM, Goodpaster BH. Role of intramyocelluar lipids in human health. Trends Endocrinol Metab 2012; 23:391-398.
75. Ramanathan A, Schreiber SL. Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A 2009; 106:22229-22232.
76. Schieke SM, Phillips D, McCoy JP Jr, et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281:27643-27652.
77. Cunningham JT, Rodgers JT, Arlow DH, et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007; 450:736-740.
78. Bentzinger CF, Romanino K, Cloetta D, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008; 8:411-424.
79. Morita M, Gravel SP, Chenard V, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-Dependent translational regulation. Cell Metab 2013; 18:698-711.
80. Mottillo EP, Bloch AE, Leff T, et al. Lipolytic products activate peroxisome proliferator-Activated receptor (PPAR) alpha and delta in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem 2012; 287:25038-25048.
81. Haemmerle G, Moustafa T, Woelkart G, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-Alpha and PGC-1. Nat Med 2011; 17:1076-1085.
82. Ong KT, Mashek MT, Bu SY, et al. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 2011; 53:116-126.
83. Ong KT, Mashek MT, Davidson NO, et al. Hepatic ATGL mediates PPARalpha signaling and fatty acid channeling through an L-FABP independent mechanism. J Lipid Res 2014; 55:808-815.
84. Khan SA, Sathyanarayan A, Mashek MT, et al. ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1alpha/PPAR-Alpha signaling. Diabetes 2015; 64:418-426.
85. Tang T, Abbott MJ, Ahmadian M, et al. Desnutrin/ATGL activates PPARdelta to promote mitochondrial function for insulin secretion in islet beta cells. Cell Metab 2013; 18:883-895.
86. Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-Associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A 2002; 99:4319-4324.
87. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 2007; 8:870-879.
88. Jheng HF, Tsai PJ, Guo SM, et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 2012; 32:309-319.
89. Palmer CS, Osellame LD, Stojanovski D, et al. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011; 23:1534-1545.
90. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006; 125:1241-1252.
91. Chen H, Chan DC. Physiological functions of mitochondrial fusion. Ann NY Acad Sci 2010; 1201:21-25.
92. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006; 45:42-72.
93. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011; 60:2441-2449.
94. Khamzina L, Veilleux A, Bergeron S, et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146:1473-1481.
95. Ost A, Svensson K, Ruishalme I, et al. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med 2010; 16:235-246.
96. Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine reviews 2002; 23:201-229.